Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Opportunities / Associate Membership Program

Associate Membership Program

The Associate Membership is designed for investigators who are not affiliated with EDRN and wish to propose collaborative studies within the scope and objectives of the EDRN. Investigators planning to become Associate Members are assigned, based on expertise and interest, to one of four site-specific Collaborative Groups: Breast and Gynecologic Cancers; Gastrointestinal and Other Cancers; Lung and Upper Aerodigestive Tract Cancers; or Prostate and Other Urologic Cancers. Investigators' primary contacts are the EDRN Principal Investigators who chair the Collaborative Groups. For details concerning the application process please read the Application Procedure instructions.

There are three categories for Associate Membership:

Category A Members are domestic or foreign investigators who propose to conduct basic or translational research consistent with the priorities of the EDRN. Supplemental funds provided through Category A Membership are to be used as one-time "seed money" for pilot studies necessary to support applications for future independent funding. Funds are provided for a period of two years and are not renewable. Although support of Category A Members ceases after two years, they are considered to be Associate Members for the duration of the EDRN. Category A Associate Members are invited to participate in Workshops and Steering Committee meetings. The "seed money" will be $50,000 per year for two years in direct costs with additional “Facilities and Administrative” costs (F&A costs).  The applicants are highly encouraged to budget in a way that they can attend two EDRN meetings per year.

Category B Members contribute to the Network by sharing available technologies, contributing specimens, making available high-risk registries and cohorts, and providing other resources complementary to the Network. They can be domestic or foreign. Category B Members can reapply for funds annually (total funding amount should not exceed $100,000 in direct costs with additional “F&A costs”, unless the Network needs determined by the EC justify additional funding).  Category B Members are considered Associate Members after funding ceases for the duration of the EDRN. Category B Associate Members are invited to participate in Workshops and Steering Committee meetings. Any clinical or laboratory site (other than current BDLs, BRLs and CEVCs) participating in a validation study are considered Category B Members.

Category C Corresponding Members, are scientists, organizations, clinicians, patient advocates, or ethicists who are interested in participating in Collaborative Group meetings and EDRN Workshops and Conferences yet do not receive funds from the EDRN. Category C Members will be invited to these meetings and conferences, but their expenses will not be supported by the EDRN. Category C members can be domestic or foreign. The application for Category C Members is the similar to that of other Associate Member applicants, with minor modifications: the budgetary document can be disregarded, and the proposal should explain how the applicant’s participation at the meetings and workshops will contribute to the mission of EDRN. Category C Members are considered Corresponding Members for the duration of the EDRN. EDRN Members for which funding has ceased are considered Category C Members for the duration of the EDRN.

Frequently Asked Questions

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 12/02/2014

New Round of EDRN FOAs

The RFAs for EDRN have been released:
- Biomarker Developmental Laboratories (U01),
- Clinical Validation Centers (U01),
- Biomarker Reference Laboratories (U24),
- Data Management and Coordinating Center (U24).

EDRN Renewal flyer NOTE-New receipt deadline for applications submitted for all EDRN FOAs is January 20, 2015, by 5:00 PM local time of applicant organization.

There will be a Pre-Application webinar to discuss each of the four individual EDRN FOAs on Tuesday, December 2nd, 2014, from 1pm-5pm (Eastern). Potential applicants interested in participating in the webinar should send a message to Dr. Sharmistha Ghosh (ghoshjanjigias@mail.nih.gov) no later than 5:00 p.m. (EST) November 21, 2014. Please mention the FOA of interest in the subject line.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.